title: Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
authors.affiliation: Department of Elderly Medicine, Morriston Hospital, Morriston, Swansea SA6 6NL, UK.
authors.forename: Claire
authors.initials: C
authors.lastname: Dinsdale
authors.forename: Mushtaq
authors.initials: M
authors.lastname: Wani
authors.forename: John
authors.initials: J
authors.lastname: Steward
authors.forename: M Sinead
authors.initials: MS
authors.lastname: O'Mahony
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000209:etiology*; D008297:Male; D051437:Renal Insufficiency / Q000209:etiology; D012189:Retrospective Studies; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013148:Spironolactone